PPT-Welcome to the Sussex-wide Cervical Screening Webinar

Host Mandeep Singh Ahluwalia Speakers  Mandeep Ahluwalia Karen Burgess Bikram Raychaudhuri Jane Lodge and Amy Dissanayake The webinar will commence at 1pm Please remember to turn off your mics and cameras. . KrisEmily. . McCrory. , MD. Objectives:. Review cervical cancer epidemiology and . pathophysiology. Identify the role of the Human . Papilloma. Virus in cervical cancer. Explain the use of HPV testing in cervical cancer screening. Based on 2012 Guidelines & Recommendations. Sarah Lamanuzzi, MD, FAAFP. Disclosures. I have no disclosures other than: the ASCCP gave permission for use of their slide content.. The American Society for Colposcopy and Cervical Pathology. “Cervical Cancer Screening Recommendations, . Based on the 2012 Recommendations (ASCCP). Sarah Lamanuzzi, MD, FAAFP. Disclosures. I have no disclosures other than: the ASCCP gave permission for use of their slide content.. The American Society for Colposcopy and Cervical Pathology. “Cervical Cancer Screening Recommendations, . Hazel Lewis. Public Health Physician. Wellington. Cartwright Forum, 7 August 2015. NCSP. -. R. centralised. 1965. 1990. 2000. 1988. Cartwright Report. NCSP . established . In 14 AHB. 1996. NSU. Gisborne Inquiry (CSI). Robert Music. Chief Executive. The impact of cervical . cancer. “As long as I can remember I had wanted children and the most distressing part of this illness is that I. . will never be able to.”. Annual CPCRN Meeting, Chicago. Tuesday, May 24. th. . Lead: Karen Glanz, PhD, MPH. Participating Sites: . UPenn. , UNC, . UWash. , CDC, NCI. This presentation was supported by Cooperative Agreement Number U48 DP005053 from the Centers for Disease Control and Prevention. The findings and conclusions in this presentation are those of the author(s) and do not necessarily represent the official position of the Centers for Disease Control and Prevention. . Prepared by : . Khalid . Aldossari. Fahad. . Alshehri. Ali Al-Mater. Supervised by : Dr. ELSHEIKH. Out lines :. WHO principles for screening tests .. HPV ( . infection , prevention , vaccination . CERVICAL CANCER. 4th most common cancer in women worldwide. CERVICAL CANCER. 4th most common cancer in women worldwide. >250,000 deaths/year. CERVICAL CANCER. 4th most common cancer in women worldwide. Cervical cancer. Cervical cancer is one of the . most preventable . cancers. Human papillomavirus (HPV). Over 99% of cervical cancer is caused by HPV. ‘Common cold of sexual activity’. Usually no symptoms. CSEB, June 10, 2016. Jason Lacombe. 1. , . Saima . Memon. 1. , Cindy Gauvreau. 1. ,. Cathy . Popadiuk. 2. , William Flanagan. 3. , Claude Nadeau. 3. , Andrew J. Coldman. 1. , Michael C. Wolfson. . 4. Cancer. (Resource-Stratified). SH-. Shiekhhasani. GYN.Oncologist. TEHRAN UNIVERSITY. Cervical cancer is the . fourth most common cancer . and . fourth leading cause of cancer-related mortality. in women worldwide.. Screening Programme. Dr G Dorman. QA Lead for Colposcopy. Cervical cancer. 80-90 new cases of invasive cervical cancer per year . 30-40 deaths per year. Associated with persistent infection with high risk subtypes of Human Papilloma Virus (HPV). . Kelly S, Mc Fadden SL. School of Life and Health Sciences, University of Ulster . Jordanstown. . Introduction. Aim. Methodology. The aetiological factors associated with cervical cancer are relatively unknown, however scientific evidence links persistent infection with human papilomavirus (HPV) and the development of cervical carcinomas. . (Preliminary Results). Hawa Camara. |. November 17. th. , 2018. Facts about Cervical cancer in PNG. 2. Experiences of PoC HPV-DNA cervical screening in PNG. Need for improved screening services. 3.